These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 18936288

  • 1. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection.
    Cathcart S, Coloe J, Morrell DS.
    Clin Pediatr (Phila); 2009 Mar; 48(2):161-5. PubMed ID: 18936288
    [Abstract] [Full Text] [Related]

  • 2. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB, Sidbury R, Mancini AJ.
    J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
    [Abstract] [Full Text] [Related]

  • 3. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA, Cathcart S, Morrell DS.
    Pediatr Dermatol; 2014 Sep; 31(4):450-4. PubMed ID: 24383663
    [Abstract] [Full Text] [Related]

  • 4. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J, Morrell DS.
    Pediatr Dermatol; 2009 Sep; 26(4):405-8. PubMed ID: 19689514
    [Abstract] [Full Text] [Related]

  • 5. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V, Cathcart S, Burkhart CN, Morrell DS.
    Dermatol Ther; 2013 Sep; 26(6):445-51. PubMed ID: 24552407
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
    Vakharia PP, Chopra R, Silverberg NB, Silverberg JI.
    Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988
    [Abstract] [Full Text] [Related]

  • 7. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
    Ross GL, Orchard DC.
    Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
    [Abstract] [Full Text] [Related]

  • 8. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
    Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS.
    Pediatr Dermatol; 2014 May; 31(4):440-9. PubMed ID: 22897595
    [Abstract] [Full Text] [Related]

  • 9. Cantharidin: a comprehensive review of the clinical literature.
    Torbeck R, Pan M, DeMoll E, Levitt J.
    Dermatol Online J; 2014 Jun 15; 20(6):. PubMed ID: 24945640
    [Abstract] [Full Text] [Related]

  • 10. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF, McFalda W, Brabec B, Siegfried E, Kwong P, McBride M, Rieger J, Willson C, Davidson M, Burnett P.
    JAMA Dermatol; 2020 Dec 01; 156(12):1315-1323. PubMed ID: 32965495
    [Abstract] [Full Text] [Related]

  • 11. Treatment of molluscum contagiosum with cantharidin: a practical approach.
    Mathes EF, Frieden IJ.
    Pediatr Ann; 2010 Mar 01; 39(3):124-8, 130. PubMed ID: 20302243
    [Abstract] [Full Text] [Related]

  • 12. Cantharidin: a valuable office treatment of molluscum contagiosum.
    Funt TR, Mehr KA.
    South Med J; 1979 Aug 01; 72(8):1019. PubMed ID: 472800
    [Abstract] [Full Text] [Related]

  • 13. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, Willson C, Davidson M, Burnett P, Olivadoti M.
    Am J Clin Dermatol; 2021 Mar 01; 22(2):257-265. PubMed ID: 33599960
    [Abstract] [Full Text] [Related]

  • 14. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children.
    Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, Thibeault H, McCuaig C.
    Pediatr Dermatol; 2006 Mar 01; 23(6):574-9. PubMed ID: 17156002
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK, Schairer DO, Garelik JL, Cohen SR.
    Int J Dermatol; 2018 Aug 01; 57(8):1001-1006. PubMed ID: 29904968
    [Abstract] [Full Text] [Related]

  • 16. Cantharidin treatment for recalcitrant facial flat warts: a preliminary study.
    Kartal Durmazlar SP, Atacan D, Eskioglu F.
    J Dermatolog Treat; 2009 Aug 01; 20(2):114-9. PubMed ID: 18821118
    [Abstract] [Full Text] [Related]

  • 17. Spread of cantharidin after petrolatum use resulting in a varicelliform vesicular dermatitis.
    Shah A, Treat J, Yan AC.
    J Am Acad Dermatol; 2008 Aug 01; 59(2 Suppl 1):S54-5. PubMed ID: 18625390
    [No Abstract] [Full Text] [Related]

  • 18. Cantharidin treatment of molluscum contagiosum.
    Epstein E.
    Acta Derm Venereol; 1989 Aug 01; 69(1):91-2. PubMed ID: 2563620
    [No Abstract] [Full Text] [Related]

  • 19. One-year experience with candida antigen immunotherapy for warts and molluscum.
    Maronn M, Salm C, Lyon V, Galbraith S.
    Pediatr Dermatol; 2008 Aug 01; 25(2):189-92. PubMed ID: 18429776
    [Abstract] [Full Text] [Related]

  • 20. Religious objection to cantharidin use in Jain patients.
    Patel D, Shwayder T.
    Pediatr Dermatol; 2013 Aug 01; 30(3):389. PubMed ID: 22380659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.